Verrills NM - Search Results

1

Alterations in gamma-actin and tubulin-targeted drug resistance in childhood leukemia.

Verrills NM, Po'uha ST, Liu ML, Liaw TY, Larsen MR, Ivery MT, Marshall GM, Gunning PW, Kavallaris M. Verrills NM, et al. J Natl Cancer Inst. 2006 Oct 4;98(19):1363-74. doi: 10.1093/jnci/djj372. J Natl Cancer Inst. 2006. PMID: 17018783

2

Anticancer therapy with novel tubulin-interacting drugs.

Kavallaris M, Verrills NM, Hill BT. Kavallaris M, et al. Among authors: verrills nm. Drug Resist Updat. 2001 Dec;4(6):392-401. doi: 10.1054/drup.2002.0230. Drug Resist Updat. 2001. PMID: 12030786 Review.

3

Drug resistance mechanisms in cancer cells: a proteomics perspective.

Verrills NM, Kavallaris M. Verrills NM, et al. Curr Opin Mol Ther. 2003 Jun;5(3):258-65. Curr Opin Mol Ther. 2003. PMID: 12870435 Review.

4

Microtubule alterations and mutations induced by desoxyepothilone B: implications for drug-target interactions.

Verrills NM, Flemming CL, Liu M, Ivery MT, Cobon GS, Norris MD, Haber M, Kavallaris M. Verrills NM, et al. Chem Biol. 2003 Jul;10(7):597-607. doi: 10.1016/s1074-5521(03)00141-8. Chem Biol. 2003. PMID: 12890533

5

Proteome analysis of vinca alkaloid response and resistance in acute lymphoblastic leukemia reveals novel cytoskeletal alterations.

Verrills NM, Walsh BJ, Cobon GS, Hains PG, Kavallaris M. Verrills NM, et al. J Biol Chem. 2003 Nov 14;278(46):45082-93. doi: 10.1074/jbc.M303378200. Epub 2003 Aug 29. J Biol Chem. 2003. PMID: 12949081 Free article.

6

Neuronal-associated microtubule proteins class III beta-tubulin and MAP2c in neuroblastoma: role in resistance to microtubule-targeted drugs.

Don S, Verrills NM, Liaw TY, Liu ML, Norris MD, Haber M, Kavallaris M. Don S, et al. Among authors: verrills nm. Mol Cancer Ther. 2004 Sep;3(9):1137-46. Mol Cancer Ther. 2004. PMID: 15367708

7

Tissue-specific tropomyosin isoform composition.

Schevzov G, Vrhovski B, Bryce NS, Elmir S, Qiu MR, O'neill GM, Yang N, Verrills NM, Kavallaris M, Gunning PW. Schevzov G, et al. Among authors: verrills nm. J Histochem Cytochem. 2005 May;53(5):557-70. doi: 10.1369/jhc.4A6505.2005. J Histochem Cytochem. 2005. PMID: 15872049

8

Improving the targeting of tubulin-binding agents: lessons from drug resistance studies.

Verrills NM, Kavallaris M. Verrills NM, et al. Curr Pharm Des. 2005;11(13):1719-33. doi: 10.2174/1381612053764706. Curr Pharm Des. 2005. PMID: 15892670 Review.

9

Proteomic analysis reveals a novel role for the actin cytoskeleton in vincristine resistant childhood leukemia--an in vivo study.

Verrills NM, Liem NL, Liaw TY, Hood BD, Lock RB, Kavallaris M. Verrills NM, et al. Proteomics. 2006 Mar;6(5):1681-94. doi: 10.1002/pmic.200500417. Proteomics. 2006. PMID: 16456880

10

A role for altered microtubule polymer levels in vincristine resistance of childhood acute lymphoblastic leukemia xenografts.

Ong V, Liem NL, Schmid MA, Verrills NM, Papa RA, Marshall GM, Mackenzie KL, Kavallaris M, Lock RB. Ong V, et al. Among authors: verrills nm. J Pharmacol Exp Ther. 2008 Feb;324(2):434-42. doi: 10.1124/jpet.107.128926. Epub 2007 Nov 6. J Pharmacol Exp Ther. 2008. PMID: 17986648

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73 results

Search Page

Filters